Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Bovine Type III Collagen-Solution

Cat. No:
1240-02S
Purified Bovine Type III Collagen solution for use as a coating material and standard.
$175.00
Size Price (USD) Quantity
0.5 mg $175.00
More Information
Description Collagen is the main structural protein in the extracellular space and is the most abundant protein in the ECM. Collagens are divided into two classes - fibril (types I, II, III, V) and non-fibril (types IV, VI). Type III collagen is expressed in the skin and a variety of internal organs including the lungs, intestinal walls, uterus, and walls of blood vessels and is often associated with type I collagen. It also interacts with platelets in the blood clotting cascade. Type III collagen mutations are associated in a range of diseases including the vascular form of Ehlers–Danlos syndrome. Type III collagen is formed by homotrimers of α1(III) chains.
Source Placental villi
Purity > 90% by SDS-PAGE
Purification Method Controlled and limited pepsin digestion followed by selective salt precipitation
Buffer Formulation 500 mM acetic acid
Concentration 0.5 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications SDS-PAGE – Quality tested
ELISA – Reported in literature 1
Surface Plasmon Resonance – Reported in literature 2
In vivo Assays – Reported in literature 4
Coating Material for –
Adhesion Studies – Reported in literature 2
Differentiation Studies – Reported in literature 3


Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Stalling SS, Nicoll SB. Fetal ACL fibroblasts exhibit enhanced cellular properties compared with adults. Clin Orthop Relat Res. 2008;466:3130-7. (ELISA, Standard Curve)
  2. 2. House-Pompeo K, Boles JO, Höök M. Characterization of bacterial adhesin interactions with extracellular matrix components utilizing biosensor technology. Methods. 1994;6:134-42. (SPR, Coating, Adhesion Studies)
  3. 3. Santiago JA, Pogemiller R, Ogle BM. Heterogeneous differentiation of human mesenchymal stem cells in response to extended culture in extracellular matrices. Tissue Eng Part A. 2009;15:3911-22. (Coating, Differentiation Studies)
  4. 4. Zhang ZY, Lee CS, Lider O, Weiner HL. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol. 1990;145:2489-93. (In vivo Assays)